Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 0 0.000% |
-2,000,000 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Entera Bio Ltd. ENTX |
RA Capital Management, L.P. | 295,966 1.000% |
-2,057,034 (-87.42%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | IO Biotech, Inc. IOBT |
RA Capital Management, L.P. | 1,127,260 3.900% |
-730,495 (-39.32%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Instil Bio, Inc. TIL |
RA Capital Management, L.P. | 0 0.000% |
-383,540 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 7,691,990 9.990% |
-41,086,182 (-84.23%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 7,040,622 9.600% |
2,075,034 (+41.79%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 3,984,681 6.200% |
-1,629,747 (-29.03%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | IMARA Inc. IMRA |
RA Capital Management, L.P. | 812,681 12.400% |
7,475 (+0.93%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA Capital Management, L.P. | 6,428,483 9.990% |
2,876,975 (+81.01%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Geron Corporation GERN |
RA Capital Management, L.P. | 48,423,211 9.990% |
16,034,412 (+49.51%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RA Capital Management, L.P. | 0 0.000% |
-2,246,503 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
RA Capital Management, L.P. | 0 0.000% |
-2,282,173 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
RA Capital Management, L.P. | 0 0.000% |
-2,850,000 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | NanoString Technologies, Inc. NSTGQ |
RA Capital Management, L.P. | 143,900 0.300% |
-3,373,794 (-95.91%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
RA Capital Management, L.P. | 0 0.000% |
-2,000,000 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | BCLS Acquisition Corp. BLSA |
RA Capital Management, L.P. | 0 0.000% |
-1,250,000 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | HilleVax, Inc. HLVX |
RA Capital Management, L.P. | 1,760,019 5.300% |
1,760,019 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Orchestra BioMed Holdings, Inc. OBIO |
RA Capital Management, L.P. | 610,283 5.400% |
610,283 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
RA Capital Management, L.P. | 4,397,368 9.600% |
40,736 (+0.94%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
RA Capital Management, L.P. | 3,773,517 19.500% |
106,854 (+2.91%) |
Filing History |